Skip to content

Join Us
Members Area

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Publication Category: Metabolic Health

Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: Association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistance

P. Perez-Martinez; J. Delgado-Lista; A. Garcia-Rios; A. C. Tierney; H. L. Gulseth; C. M. Williams; B. Karlström; B. Kieć-Wilk; E. E. Blaak; O. Helal; W. H. M. Saris; C. Defoort; C. A. Drevon; J. A. Lovegrove; A. Dembinska-Kieć; U. Riserus; H. M. Roche; J. Insulin receptor substrate-2 gene variants in subjects with metabolic syndrome: Association with plasma monounsaturated and n-3 polyunsaturated fatty acid levels and insulin resistance Molecular Nutrition and Food Research
Genetics Insulin Resistance & Diabetes Metabolic Syndrome

Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies

S. O'Neill; L. O'Driscoll Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies Obes Rev
Metabolic Syndrome

Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors

A. Omran; B. M. Leca; E. Oštarijaš; N. Graham; A. S. Da Silva; Z. M. Zaïr; A. D. Miras; C. W. le Roux; R. P. Vincent; L. Cardozo; G. K. Dimitriadis Metabolic syndrome is associated with prostate enlargement: a systematic review, meta-analysis, and meta-regression on patients with lower urinary tract symptom factors Ther Adv Endocrinol Metab
Metabolic Syndrome

ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria

E. Noctor; C. Crowe; L. A. Carmody; B. Kirwan; A. O’Dea; L. G. Glynn; B. E. McGuire; P. M. O’Shea; F. P. Dunne ATLANTIC-DIP: prevalence of metabolic syndrome and insulin resistance in women with previous gestational diabetes mellitus by International Association of Diabetes in Pregnancy Study Groups criteria Acta Diabetologica
Insulin Resistance & Diabetes Metabolic Syndrome

Gut microbiome of a porcine model of metabolic syndrome and HF-pEF

A. N. O'Donovan; F. M. Herisson; F. Fouhy; P. M. Ryan; D. Whelan; C. N. Johnson; G. Cluzel; R. P. Ross; C. Stanton; N. M. Caplice Gut microbiome of a porcine model of metabolic syndrome and HF-pEF Am J Physiol Heart Circ Physiol
Metabolic Syndrome

miR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome

S. O'Neill; M. B. Larsen; S. Gregersen; K. Hermansen; L. O'Driscoll miR-758-3p: a blood-based biomarker that’s influence on the expression of CERP/ABCA1 may contribute to the progression of obesity to metabolic syndrome Oncotarget
Genetics Metabolic Syndrome

Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial

B. V. Loughrey; A. McGinty; I. S. Young; D. R. McCance; L. A. Powell Increased circulating CC chemokine levels in the metabolic syndrome are reduced by low-dose atorvastatin treatment: evidence from a randomized controlled trial Clinical endocrinology
Metabolic Syndrome

Routine screening and rates of metabolic syndrome in patients treated with clozapine and long-acting injectable antipsychotic medications: a cross-sectional study

A. Lydon; J. Vallely; A. Tummon; S. Maher; S. Sabri; J. McLoughlin; A. Liew; C. McDonald; B. Hallahan Routine screening and rates of metabolic syndrome in patients treated with clozapine and long-acting injectable antipsychotic medications: a cross-sectional study Ir J Psychol Med
Metabolic Syndrome

Pathophysiology of the metabolic syndrome

E. McCracken; M. Monaghan; S. Sreenivasan Pathophysiology of the metabolic syndrome Clin Dermatol
Metabolic Syndrome

Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial

V. Mocanu; Z. Zhang; E. C. Deehan; D. H. Kao; N. Hotte; S. Karmali; D. W. Birch; K. K. Samarasinghe; J. Walter; K. L. Madsen Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial Nat Med
Insulin Resistance & Diabetes Metabolic Syndrome

Older posts

Newer posts

← Previous Page1 … Page21 Page22 Page23 … Page54 Next →

Search for:

Recent Posts

9th ASOI Annual Conference – Registration now open!
Press Release for World Obesity Day 4th March 2024
ASOI and ICPO response to : Medical Council Communication: “Important medicine shortage information – Ozempic (semaglutide)”
Things to do in Dublin during ECO
ECO 2023 sponsorship update

ASOI

info@asoi.info

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Home
ASOI News
About Us
Events
Media Resources
Public Resources
Guidelines
Research

Privacy Policy
Site Map

©2025 ASOI